jm 221 has been researched along with Ovarian Neoplasms in 3 studies
*Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abel, G; Harrap, KR; Kelland, LR; McKeage, MJ | 1 |
| Abel, G; Harrap, KR; Kelland, LR; Loh, SY; Mistry, P; Murrer, BA | 1 |
| Abel, G; Harrap, KR; Kelland, LR; Loh, SY; Mistry, P; Murrer, BA; O'Neill, CF | 1 |
3 other study(ies) available for jm 221 and Ovarian Neoplasms
| Article | Year |
|---|---|
Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro.
Topics: Antineoplastic Agents; Cisplatin; DNA Probes; DNA, Neoplasm; Drug Resistance; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Tumor Cells, Cultured | 1994 |
Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines.
Topics: Antineoplastic Agents; Cisplatin; Drug Screening Assays, Antitumor; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Tumor Cells, Cultured | 1992 |
Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.
Topics: Antineoplastic Agents; Cisplatin; DNA; DNA Adducts; DNA, Neoplasm; Drug Resistance; Drug Screening Assays, Antitumor; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Tumor Cells, Cultured | 1992 |